{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:28:21Z","timestamp":1793820501162,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.radonc.2025.110763","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T06:55:40Z","timestamp":1738392940000},"page":"110763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Comparison of definitive radiotherapy outcomes between younger and older patients with high- or very-high-risk prostate cancer"],"prefix":"10.1016","volume":"205","author":[{"given":"Yong-Hyub","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Uk","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ho","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek-Keun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mee Sun","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinhaeng","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ja","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110763_b0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4143\/crt.2024.252","article-title":"Prediction of cancer incidence and mortality in Korea, 2024","volume":"56","author":"Jung","year":"2024","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.110763_b0010","unstructured":"National Comprehensive Cancer Network. Clinical practice guidelines in oncology: Prostate cancer, Version 4. 2024. http:\/\/www.nccn.org [accessed 17 May 2024]."},{"key":"10.1016\/j.radonc.2025.110763_b0015","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/cam4.3003","article-title":"Prostate cancer in Pennsylvania: the role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry","volume":"9","author":"Bluethmann","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2025.110763_b0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jgo.2018.06.010","article-title":"Nationwide treatment patterns and survival of older patients with prostate cancer","volume":"10","author":"Vernooij","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijrobp.2013.05.044","article-title":"Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer","volume":"87","author":"Tendulkar","year":"2013","journal-title":"Int J Radiation Oncology, Biology, Physics"},{"key":"10.1016\/j.radonc.2025.110763_b0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2005.06.001","article-title":"3D conformal radiation therapy for prostate cancer in elderly patients","volume":"76","author":"Geinitz","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.urology.2004.04.043","article-title":"Influence of patient age on biochemical freedom from disease in patients undergoing conformal proton radiotherapy of organ-confined prostate cancer","volume":"64","author":"Rossi","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2025.110763_b0040","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11701-020-01144-w","article-title":"The comparison of the survival outcome between robotic-assisted radical prostatectomy and radiation therapy for localized prostate cancer in men over 70 years: Korean nationwide observational study","volume":"15","author":"Ko","year":"2021","journal-title":"J Robot Surg"},{"key":"10.1016\/j.radonc.2025.110763_b0045","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2015.01.008","article-title":"Impact of age on quality-of-life outcomes after treatment for localized prostate cancer","volume":"68","author":"Hampson","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2025.110763_b0050","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S1470-2045(14)70018-X","article-title":"Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology","volume":"15","author":"Droz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/annonc\/mdu360","article-title":"Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)","volume":"26","author":"Bellera","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0360-3016(94)90138-4","article-title":"Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer","volume":"28","author":"Roach","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110763_b0065","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110763_b0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.radonc.2025.110763_b0075","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-5347(05)64674-5","article-title":"Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation","volume":"168","author":"Rosser","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2025.110763_b0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.radonc.2011.07.022","article-title":"Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer","volume":"101","author":"Klayton","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1200\/JCO.2016.69.0834","article-title":"Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non\u2013small-cell lung cancer: a competing risks analysis","volume":"35","author":"Eguchi","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0090","unstructured":"Statistics Korea. Life tables for Korea, 2022. 2023. http:\/\/kostat.go.kr\/board.es?mid=a20108060000&bid=11746&act=view&list_no=429104 [accessed 1 Dec 2023]."},{"key":"10.1016\/j.radonc.2025.110763_b0095","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.3390\/cancers13225795","article-title":"PSMA-PET\/MRI-based focal dose escalation in patients with primary prostate cancer treated with stereotactic body radiation therapy (HypoFocal-SBRT): study protocol of a randomized, multicentric phase III trial","volume":"13","author":"Zamboglou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2025.110763_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109713","article-title":"From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial","volume":"185","author":"De Cock","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248461","article-title":"Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer","volume":"16","author":"Jeong","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2025.110763_b0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13014-017-0884-y","article-title":"Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation","volume":"12","author":"Geara","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0115","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.urology.2010.03.081","article-title":"Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy","volume":"76","author":"Hong","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2025.110763_b0120","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2025.110763_b0125","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2004.08.047","article-title":"Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma\u2014long-term results of phase III RTOG 85-31","volume":"61","author":"Pilepich","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110763_b0130","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/COC.0000000000000161","article-title":"High-risk prostate cancer treated with dose-escalated RT: an analysis of hormonal therapy use and duration, and prognostic implications of PSA nadir \u22640.2 to select men for short-term hormonal therapy","volume":"40","author":"Son","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110763_b0135","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00595-022-02628-y","article-title":"Older age is not a negative factor for video-assisted thoracoscopic lobectomy for pathological stage I non-small cell lung cancer: a single-center, retrospective, propensity score-matching study","volume":"53","author":"Fujita","year":"2023","journal-title":"Surg Today"},{"key":"10.1016\/j.radonc.2025.110763_b0140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/GME.0000000000002412","article-title":"Sex differences in all-cause mortality and life span between women with premature menopause and men: propensity score matching analysis","volume":"31","author":"Xing","year":"2024","journal-title":"Menopause"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:47:49Z","timestamp":1774417669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":28,"alternative-id":["S0167814025000581"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110763","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of definitive radiotherapy outcomes between younger and older patients with high- or very-high-risk prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110763"}}